| Literature DB >> 35940888 |
Marta Ruiz-Lopez1, Ana Moreno Estébanez2, Beatriz Tijero2, Tamara Fernandez2, Alba Rebollo-Perez2, Iñigo Gabilondo2, Nuria Lopez-Osle2, Leticia Ceberio-Hualde2, Juan Jose Zarranz2, Juan Carlos Gomez-Esteban2.
Abstract
Wilson disease (WD) is a genetic disorder of copper metabolism caused by variants in the ATP7B gene, which are inherited in an autosomal recessive pattern. Despite all the advances made on pathogenesis, cellular biology, and genetics, to date, WD remains a diagnostic and therapeutic challenge. With this series of cases, we aim to illustrate the main challenges that clinicians may encounter when dealing with patients with WD: the difficulties with clinical diagnosis, the therapeutic management of WD and the indication for advanced therapies, management during pregnancy, and genotype-phenotype correlations.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35940888 PMCID: PMC9442620 DOI: 10.1212/WNL.0000000000200836
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 11.800